DADC
MDGL icon

D.A. Davidson & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History

D.A. Davidson & Co’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$389K Sell
724
-1,099
-60% -$563K ﹤0.01% 1290
2026
Q1 		$954K Sell
1,823
-306
-14% -$146K 0.01% 947
2025
Q4 		$1.24M Buy
2,129
+58
+3% +$29.6K 0.01% 810
2025
Q3 		$950K Buy
2,071
+518
+33% +$193K 0.01% 887
2025
Q2 		$470K Sell
1,553
-620
-29% -$185K ﹤0.01% 1077
2025
Q1 		$720K Buy
2,173
+1,458
+204% +$479K 0.01% 893
2024
Q4 		$221K Buy
+715
New +$201K ﹤0.01% 1304
2024
Q3 		– Sell
-715
Closed -$200K – 1415
2024
Q2 		$200K Buy
+715
New +$170K ﹤0.01% 1285
2023
Q1 		– Sell
-720
Closed -$209K – 1389
2022
Q4 		$209K Buy
+720
New +$70.4K ﹤0.01% 1178
2019
Q1 		– Sell
-1,775
Closed -$200K – 1157
2018
Q4 		$200K Sell
1,775
-160
-8% -$24.8K ﹤0.01% 994
2018
Q3 		$414K Sell
1,935
-5
-0.3% -$1.25K 0.01% 786
2018
Q2 		$543K Sell
1,940
-995
-34% -$175K 0.01% 673
2018
Q1 		$343K Sell
2,935
-865
-23% -$107K 0.01% 823
2017
Q4 		$349K Buy
+3,800
New +$217K 0.01% 786
2017
Q3 		– Sell
-3,950
Closed -$64K – 1618
2017
Q2 		$64K Sell
3,950
-1,200
-23% -$18.8K ﹤0.01% 1440
2017
Q1 		$79K Buy
5,150
+4,650
+930% +$73.1K ﹤0.01% 1340
2016
Q4 		$7K Buy
+500
New +$8.03K ﹤0.01% 2185

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.A. Davidson & Co's MDGL Position: Q2 2026 in Review

D.A. Davidson & Co reduced its Madrigal Pharmaceuticals (MDGL) stake by 60% in Q2 2026, selling an estimated $563K and leaving 724 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

D.A. Davidson & Co first reported a position in MDGL in Q4 2016 and has held it in 17 quarters since. The position peaked at $1.24M in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • D.A. Davidson & Co held 724 shares of Madrigal Pharmaceuticals worth $389K as of Q2 2026.
  • D.A. Davidson & Co sold 1,099 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $563K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #1290 holding.
  • D.A. Davidson & Co first reported a position in Madrigal Pharmaceuticals in Q4 2016 and has held it in 17 quarters since.
  • D.A. Davidson & Co's Madrigal Pharmaceuticals position peaked at $1.24M in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.